2016
DOI: 10.1111/all.12899
|View full text |Cite
|
Sign up to set email alerts
|

The minor house dust mite allergen Der p 13 is a fatty acid‐binding protein and an activator of a TLR2‐mediated innate immune response

Abstract: Satitsuksanoa, P. et al. (2016) The minor house dust mite allergen Der p 13 is a fatty acid binding protein and an activator of a TLR2-mediated innate immune response. Allergy, 71(10), pp. 1425-1434. (doi:10.1111/all.12899) This is the author's final accepted version.There may be differences between this version and the published version. You are advised to consult the publisher's version if you wish to cite from it.http://eprints.gla.ac.uk/118175/

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
62
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(64 citation statements)
references
References 44 publications
2
62
0
Order By: Relevance
“…For the selection of clones transformed with Der p 5 cDNA, transformants were first selected for histidinol deshydrogenase‐auxotrophy (His+) followed by a screening for geneticin (G418) resistance through plating His+ clones on agar containing increasing concentrations of the antibiotic (250 to 2000 μg/mL). For a typical rDer p 5 expression assay, we followed the same protocols as previously described for rProDer p 1 and rDer p 13 . Methanol concentrations of 0.5% were added to the BMMY medium for the induction of rDer p 5 expression.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…For the selection of clones transformed with Der p 5 cDNA, transformants were first selected for histidinol deshydrogenase‐auxotrophy (His+) followed by a screening for geneticin (G418) resistance through plating His+ clones on agar containing increasing concentrations of the antibiotic (250 to 2000 μg/mL). For a typical rDer p 5 expression assay, we followed the same protocols as previously described for rProDer p 1 and rDer p 13 . Methanol concentrations of 0.5% were added to the BMMY medium for the induction of rDer p 5 expression.…”
Section: Methodsmentioning
confidence: 99%
“…Ligand binding by rDer p 5 was investigated spectrofluorometrically at pH 7.3 and 4.2 as previously described using a set a fluorescent lipid probes, the most useful of which proved to be the naturally fluorescent fatty acid cis ‐parinaric acid (cPnA, Invitrogen), the fluorophore‐tagged fatty acids 11‐([5‐dimethylaminonaphthalene‐1‐sulfonylamino]) undecanoic acid (DAUDA, Invitrogen) and dansyl‐DL‐α‐aminocaprylic acid (DACA, Merck, Darmstadt, Germany), as well as the fluorescent non‐specific probe for exposed hydrophobic surfaces in proteins, 1‐anilinonapthalene‐8‐sulfonate (ANS, Merck). The bis form of ANS was also used but the results using it were essentially the same as for ANS.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Among HDM allergens, Der p 13 can bind fatty acid and induce TLR2-associated immune response. 28 Considering PAM is a synthetic triacylated lipopeptide, part of HDM allergens like Der p 13 may be capable of combining with PAM and cooperate in activating TLR2. To exclude the possibility that other innate immune receptors except TLR2, TLR4 and dectin-1 are involved in these effects, further studies will be necessary.…”
Section: F I G U R E 5 Evaluation Of Contribution Of B Cells and T Cementioning
confidence: 99%
“…Information about a detailed allergenicity evaluation is currently available for only 10% of all IgE binding proteins in the databases. Completing this task will allow a better assessment of the pathogenic role of each mite allergen as has been recently suggested for Der p 23 [17,18] and could be great independently of its IgE-binding frequency [19][20][21]. Recognizing that regional combinations of mite allergens are more appropriate and less expensive than large panels of just IgE-binding components will also help.…”
Section: Mite Allergens and Precision Medicinementioning
confidence: 94%